Unfortunately, due to the limited number of studies available, we could not provide a detailed subgroup analysis based on the specific GLP-1RAs classifications, procedure type, baseline patient characteristics, and the timing of therapy initiation
Found clinicians have booked more than one million consultations and helped more than 250,000 people lose weight
The funding bodies had no role in the writing of this review
The trial took place for 104 weeks
Contact your GP or diabetes specialist if you experience: Severe or worsening fatigue that significantly impairs daily functioning or persists despite self-management strategies Signs of dehydration including dark urine, dizziness, rapid heartbeat, or confusion Symptoms suggesting hypoglycaemia (low blood glucose) such as shakiness, sweating, confusion, or palpitations, particularly if you take insulin or sulfonylureas Persistent nausea or vomiting preventing adequate food or fluid intake Unintentional, rapid, or concerning weight loss , or inability to maintain adequate nutrition Symptoms of nutritional deficiency including pale skin, shortness of breath, tingling in hands or feet, or muscle weakness Seek urgent medical attention if you develop: Severe, persistent abdominal pain (with or without vomiting) may indicate pancreatitis Right upper abdominal pain, fever, or yellowing of skin/eyes possible gallbladder problems Severe dehydration or significantly reduced urination risk of kidney problems Signs of allergic reaction such as rash, swelling, or difficulty breathing Your GP may recommend blood tests to assess for anaemia, thyroid function, kidney function, and other causes of fatigue based on your symptoms
